MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Patterns of Striatal DAT Binding Loss in a Progressing Parkinson Disease (PD) Cohort: Four year PPMI Follow-up

    J. Seibyl, K. Marek (New Haven, CT, USA)

    Objective: To evaluate within subject striatal changes in dopamine transporter (DAT) binding using 123-I Ioflupane SPECT in PD participants studied over four years in the…
  • 2017 International Congress

    Prof. Wadia’s contributions to neurology and SCA2

    F. Tensini, J. Pedroso, O. Barsottini, H. Teive (Curiitiba, Brazil)

    Objective: To present a review of the seminal contributions of Professor Wadia to neurology, in particular the first description of SCA2. Background: Spinocerebellar ataxia type…
  • 2017 International Congress

    Diagnostic utility of regional [18F]AV-1451 tau-PET measurements in PSP

    J. Whitwell, V. Lowe, N. Tosakulwong, S. Weigand, M. Senjem, C. Schwarz, A. Spychalla, R. Petersen, C. Jack, K. Josephs (Rochester, MN, USA)

    Objective: To determine the diagnostic utility of regional subcortical [18F]AV-1451 tau-PET measurements to differentiate progressive supranuclear palsy (PSP) from age-matched controls and Alzheimer’s dementia patients.…
  • 2017 International Congress

    Occupational trichloroethylene exposure and Parkinson’s disease risk

    S. Goldman, P. Quinlan, C. Meng, K. Comyns, G.W. Ross, K. Marek, C. Tanner (San Francisco, CA, USA)

    Objective: To assess whether occupational exposure to the solvent trichloroethylene (TCE) is associated with increased risk of Parkinson's disease (PD). Background: Severe solvent intoxication can…
  • 2017 International Congress

    Tonsillectomy and risk of Parkinson’s disease: A Danish nationwide population-based cohort study

    E. Svensson, V. Henderson, S. Szépligeti, M. Stokholm, T. Klug, H. Sørensen, P. Borghammer (Aarhus, Denmark)

    Objective: To our knowledge, no studies have examined whether the lymphoid tissue of the tonsils are involved PD, or whether tonsillectomy modifies the risk of PD.…
  • 2017 International Congress

    Circadian and Homeostatic Modulation of Multi-unit Activity in Dopaminergic and Striatal Structures

    K. Fifel (Leiden, Netherlands)

    Objective: The aim of this study is to investigate the circadian and homeostatic modulation of the multi-unit activity of dopamineric and striatal neuronal structures. Background:…
  • 2017 International Congress

    Two-year prospective study reveals that gut dysbiosis predicts progression of Parkinson’s disease

    M. Hirayama, T. Minato, Y. Fujisawa, H. Tsuji, T. Asahara, K. Nomoto, T. Maeda, K. Ohno (Nagoya, Japan)

    Objective:  This study is to examine whether intestinal microbiota correlate with pathology progress of PD severity and change of gut microbiota for 2 years. Background:…
  • 2017 International Congress

    Relationship between sleep profiles and clinical features in Parkinson’s disease

    Y.-Y. Lin, R.-S. Chen, C.-S. Lu, Y.-Z. Huang, Y.-H. Weng, T.-H. Yeh, W.-Y. Lin, J. Hung (Taoyuan, Taiwan)

    Objective: To document the prevalence of sleep disturbance and excessive daytime sleepiness (EDS) in Taiwanese Parkinson’s disease (PD) patients and to identify the risk factors…
  • 2017 International Congress

    Does gender influence the expression of non-motor symptoms in Parkinson’s disease?: An observational study

    J. Herreros Rodríguez, A. Esquivel López, R. Gordo Mañas, Á. Sánchez Ferro (Madrid, Spain)

    Objective: Our goal was to evaluate how gender influenced the expression of non-motor symptoms in a sample of PD patients. Background: Parkinson’s Disease (PD) is defined…
  • 2017 International Congress

    Histological analysis of α-synuclein pathology in the circadian system in Parkinson’s disease

    E. De Pablo-Fernandez, J. Holton, T. Warner (London, United Kingdom)

    Objective: Assessment of severity of α-synuclein pathology in the circadian system in patients with Parkinson’s disease (PD). Background: Circadian system is responsible for the 24-hour…
  • « Previous Page
  • 1
  • …
  • 129
  • 130
  • 131
  • 132
  • 133
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley